U.S. Markets closed

Theralase Technologies Inc. (TLT.V)


TSXV - TSXV Delayed Price. Currency in CAD
Add to watchlist
0.36-0.00 (-1.37%)
At close: 3:40PM EDT
People also watch
ZMS.VPHM.VTLTFFCXV.VSBM.V

Theralase Technologies Inc.

1945 Queen Street East
Toronto, ON M4L 1H7
Canada
416-699-5273
http://www.theralase.com

SectorHealthcare
IndustryMedical Appliances & Equipment
Full Time Employees

Key Executives

NameTitlePayExercisedAge
Mr. Roger John Dumoulin-White P.Eng. (Electrical)Chairman, Pres & Chief Exec. Officer313.7kN/AN/A
Ms. Kristina HacheyChief Financial Officer133.33kN/AN/A
Dr. Arkady Mandel M.D., Ph.D., DSc.Chief Scientific Officer142.08kN/AN/A
Mr. David SmithDirector of SalesN/AN/AN/A
Ms. Crystel FigaroDirector of MarketingN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Theralase Technologies Inc. designs, develops, manufactures, and markets super-pulsed cold laser technology for a range of human, companion animal, and equine applications. The company operates in two divisions, Therapeutic Laser Technology and Photo Dynamic Therapy. It engages in the production, marketing, and distribution of TLC-1000 and TLC-2000 laser technology for the treatment of nerve, muscle, tendon, ligament, joint, and wound conditions through the elimination of pain, reduction of inflammation, and acceleration of tissue healing. The company is also involved in the research, development, and commercialization of the patented and patent pending TLC-3000 medical laser and photo dynamic compound anti-cancer technology through preclinical research, clinical trials, and technology development to destroy cancers for oncological applications, as well as to destroy bacteria for human, animal, and sterilization applications. In addition, it operates a full service medical rehabilitation clinic in Toronto, Ontario for training and education of health-care practitioners. The company sells its products to licensed healthcare practitioners in Canada and the United States. Theralase Technologies Inc. has strategic partnerships with University Health Network, Ontario Centers of Excellence for Photonics, National Research Council of Canada, Virginia Tech, The Scripps Research Institute, Mayo Clinic, University of Buffalo, and JSS Medical Research, as well as clinical research agreements with Princess Margaret Cancer Centre and University Health Network. The company was founded in 1994 and is based in Toronto, Canada.

Corporate Governance

Theralase Technologies Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.